Ranbaxy SWOT Analysis, Competitors & USP

Posted in Pharma and Healthcare, Total Reads: 11190

SWOT analysis of Ranbaxy analyses the brand/company with its strengths, weaknesses, opportunities & threats. In Ranbaxy SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like Ranbaxy to benchmark its business & performance as compared to the competitors and industry. Ranbaxy is one of the leading brands in the pharma and healthcare sector. The table below also lists the top Ranbaxy competitors and elaborates Ranbaxy market segmentation, target group, positioning & Unique Selling Proposition (USP).

Ranbaxy SWOT, Competitors, Marketing STP & Brand analysis Table
Ranbaxy Brand Analysis
Parent Company





Pharma and Healthcare

Tagline/ Slogan

New boundaries, new Horizons; Trusted medicines healthier lives


It is India’s largest pharmaceutical company

Ranbaxy STP

Anti-Infectives, Cardiovascular & Diabetes, Dermatological, Neuro-Psychiatry, Pain management, Gastro-Intestinal, Nutritional

Target Group

Healthcare professionals, wholesalers, generic distributors, and hospitals


A diversifies global healthcare company focused on patient’s needs

Ranbaxy SWOT Analysis

Below is the Strengths, Weaknesses, Opportunities & Threats (SWOT) Analysis of Ranbaxy. Strengths are:

1.Top 10 Global Generic Company with a spread over 125 countries

2. over 13,000 well trained Employees, over 50 nationalities

3. Strong presence in the International market with a major share and a strong presence in India as well

4.It has operations in nearly 50 countries and has 7 manufacturing plants


Here are the weaknesses in the Ranbaxy SWOT Analysis:

1. It is heavily dependent upon generics for its revenue generation

2. Constantly regulated policies by the govt means operational efficiency is affected


Following are the Opportunities in Ranbaxy SWOT Analysis:

1.increasing health awareness

2.Improvement in distribution network & brand building

3. They can leverage  Synriam, anti-malarial drug in brand building


The threats in the SWOT Analysis of Ranbaxy are as mentioned:

1.Increasingly stringent FDA Regulations

2.Exchange rate fluctuations

3.Global economic slowdown

Ranbaxy Competition

Below are the top 4 Ranbaxy competitors:

1. Sun Pharma Industries
2. Dr.Reddy's

3. Lupin

4. GlaxoSmithKline Pharmaceuticals Ltd

The brandguide table above concludes the Ranbaxy SWOT analysis along with its marketing and brand parameters.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Ranbaxy. The BrandGuide section covers SWOT Analysis, USP, STP & Competition of more than 6000 brands from over 20 categories. This SWOT and marketing analysis has been researched & authored by our BrandGuide Research Team members.

Search & Explore : BrandGuide

The brand names and other brand information used in the BrandGuide section are properties of their respective companies. The companies are not associated with MBASkool in any way. The brand names are used purely for educational/academic purpose only. Utmost care has been taken in the analysis of the brands. However, if you find any ambiguity kindly help us improve.

Edit the Brand or Add a New One : Contribute to BrandGuide
Share this Page on:
Facebook ShareTweetShare on Linkedin